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Abstract: Highly stable dispersions of nanosized silver particles were synthesized using a 
straightforward, cost-effective, and ecofriendly method. Nontoxic glucose was utilized as a 
reducing agent and poly-α, γ, L-glutamic acid (PGA), a naturally occurring anionic   polymer, 
was used as a capping agent to protect the silver nanoparticles from agglomeration and 
  render them biocompatible. Use of ammonia during synthesis was avoided. Our study clearly 
demonstrates how the concentration of the capping agent plays a major role in determining 
the dimensions, morphology, and stability, as well as toxicity of a silver colloidal solution. 
Hence, proper optimization is necessary to develop silver colloids of narrow size distribution. 
The samples were characterized by Fourier transform infrared spectroscopy, ultraviolet-visible 
spectroscopy, field-emission scanning electron microscopy, transmission electron microscopy, 
and zeta potential measurement. MTT assay results indicated good biocompatibility of the PGA-
capped silver nanoparticles. Formation of intracellular reactive oxygen species was measured 
spectrophotometrically using 2,7-dichlorofluorescein diacetate as a fluorescent probe, and it 
was shown that the PGA-capped silver nanoparticles did not induce intracellular formation of 
reactive oxygen species.
Keywords: silver nanoparticles, poly-α, γ, L-glutamic, green synthesis, morphology, 
cytotoxicity
Introduction
In recent years, nanoscience has increased and expanded from a multidisciplinary 
research concept to a primary scientific frontier. Rapid technological advancements 
have led to the expansion of nanoscale device components, advanced sensors, and 
novel biomimetic materials.1,2 Among the noble metals, silver nanoparticles have 
received considerable attention due to their attractive physicochemical properties, such 
as   magnetic and optical polarizability, electrical conductivity, catalysis, antimicrobial 
behavior, DNA sequencing, surface-enhanced Raman scattering, and thermal 
properties.3,4 Silver nanoparticles have been found to have strong antimicrobial activity, 
and are used in wound dressings, contraceptive devices, surgical instruments, bone 
prostheses, and as coating for ocular lenses to prevent microbial activity.2,5,6 However, 
the potentially negative impacts of nanomaterials are sometimes overlooked during 
the discovery phase of research. The implementation of green chemistry principles 
can enhance nanoscience by maximizing safety and efficiency, while minimizing the 
environmental and societal impacts of these materials.1
The general principle of synthesis of metal nanoparticles from a salt solution is 
based on using a reducing agent in the presence of a capping agent. Commonly used International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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reductants include borohydride, citrate, ascorbate, elemental 
hydrogen, tetrabutylammonium borohydride, organometallic 
compounds, dimethylformamide, potassium bitartrate, 
alcohols, and polyols.7–13 Capping agents prevent nano-
particles from agglomerating, as well as modifying 
their morphology. Polyvinyl pyrrolidone, polyvinyl 
alcohol, gelatin, carboxymethylcellulose, polyacrylnitrile, 
starch, gelatin, heparin, chitosan, bovine serum albumin, 
polysaccharides, and oleylamine are the most often used 
capping agents for silver nanoparticles.14–18 A problem 
which can occur with the particle stabilizer is the difficulty 
of removing it from the system, and this is addressed in 
the literature.19 The remains of the stabilizer often modify 
the surface characteristics of the particles, thus affecting 
biocompatibility and distribution throughout the body.19 
Therefore, it is necessary to determine accurately the 
concentration of stabilizers for any given method.
Herein we demonstrate, for the first time, a simple and 
quick method of synthesis of uniform and stable silver 
nanoparticles, using nontoxic glucose as the reduction 
agent, poly-α, γ, L-glutamic acid (PGA) as the capping 
agent, and without using ammonia. A number of researchers 
have successfully synthesized silver nanoparticles, but use 
of this green, one-pot, four-component method overcomes 
some of the disadvantages previously reported using other 
methods, such as impurities, solvent toxicity, difficulty in 
controlling particle size and distribution, economic viability, 
and problems in preparation that limit their commercialization 
potential.12,15,18,20 The major advantage of this method of 
synthesis of silver nanoparticles, relative to other methods, 
is most certainly use of PGA as the capping agent. PGA is 
a nontoxic, hydrophilic, and biodegradable polymer utilized 
to enhance the stability and cytocompatibility of silver 
nanoparticles. PGA is a naturally occurring, multifunctional, 
biodegradable biopolymer of L-glutamic acid produced by 
fermentation with Bacillus subtilis,21 and has been developed 
rapidly in the last two decades.21 Incorporation of PGA 
into an antigenic formulation, influenza vaccine, and gene 
transfection carrier has led to improved pharmaceutical 
efficacy.21
The use of PGA as a capping agent has already been 
reported by another group,22 but with use of ammonia in the 
synthesis, which was avoided using our method. Ammonia 
is a very corrosive and hazardous chemical, so is avoided 
in a number of other reported synthesis procedures, with 
use of alternative chemicals as reducing and/or capping 
agents, eg, sodium borohydride, dimethyl formamide, and 
cetyltrimethylammonium bromide.7–9,13,23,24 However, there 
is a general concern about these products because of their 
potential environmental and biological risks. These studies 
have also contributed to our understanding of the role played 
by a capping agent in size, morphology, and stability control. 
To address this issue, we have done a series of experiments 
under identical conditions (ie, precursor, temperature, reduc-
tant, concentrations of reagents, and reaction time) except 
for the use of different concentrations of capping agent. 
We found that particles of varying shape, size, uniformity, 
agglomeration, and stability could be produced by adding 
different amounts of capping agent.
The environmental and health impact of nanomaterials is 
becoming an important topic in research over recent years. 
The unique advantages offered by these nanomaterials in 
a wide range of applications cannot be realized until these 
  concerns are resolved.25 As shown by toxicokinetic studies, 
the liver is expected to be the major organ for systemic 
toxicity of silver nanoparticles.26 Therefore, in our study, we 
used a test system of human HepG2 hepatoma cells in order 
to evaluate the in vitro cytotoxic potential of bare and PGA-
capped silver nanoparticles using the 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
Recent studies have pointed to a higher toxic potential using 
nanomaterials than their larger counterparts, probably due to 
oxidative stress as a consequence of increased production of 
reactive oxygen species.27,28 In this study, we also determined 
whether bare and PGA-capped silver nanoparticles could 
cause increased production of reactive oxygen species.
Materials and methods
Materials
Silver nitrate (AgNO3, molar ratio 169.88) was obtained from 
Centrohem (Stara Pazova, Serbia), glucose (C6H12O6, molar 
ratio 180.20) from Zorka Pharma (Sabac, Serbia), and sodium 
hydroxide (NaOH, molar ratio 40.00) from Kemika (Zagreb, 
Croatia). PGA with a molecular weight of 20–40 kDa (99.9% 
high-pressure liquid chromatography purity) was purchased 
from Guilin Peptide Technology Limited (Guangxi, China). 
All reagents were of analytic grade and used as received 
without further purification.
Chemicals, ie, Eagle’s minimal essential medium, 
penicillin/streptomycin, L-glutamine, phosphate-buffered 
saline, trypsin, fetal bovine serum, nonessential amino 
acid solution (100×), MTT, dimethyl sulfoxide, tert-butyl 
hydroperoxide (t-BOOH) and 2,7-dichlorofluorescein 
diacetate (DCFH-DA) used for determining cytotoxicity and 
formation of reactive oxygen species were obtained from 
Sigma-Aldrich (St Louis, MO).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Methods
green synthesis of bare and PgA-capped 
silver nanoparticles
The route to synthesis of silver nanoparticles with and 
without PGA as the capping layer and without use of 
ammonia is new, simple, and completely green. Bare and 
PGA-capped silver nanoparticles were synthesized using a 
chemical reduction method whereby silver nitrate, glucose, 
and PGA served as a precursor, a reduction agent, and a 
capping agent, respectively.
The initial solution used in all syntheses was 20 mL of 
distilled water into which 0.5 mL (0.5 wt%) NaOH, 10 mL 
(1 wt%) glucose, and 0.5 mL (0.1 wt%) AgNO3 were 
introduced, with continuous stirring on a magnetic stirrer 
at 300 rpm. Glucose in an alkaline solution is oxidized 
by oxygen, forming gluconic acid, which is converted to 
sodium gluconate, a noncorrosive and nontoxic compound 
used as a food additive or fortifier of sodium in the presence 
of sodium hydroxide. Silver nitrate speeds up the reaction 
by acting as an oxidizing agent. As glucose is oxidized by 
dissolved oxygen, silver ions are reduced, forming silver 
nanoparticles, and the solution takes on a yellow-green color. 
For the formation of the capped silver nanoparticles, 0.5 mL 
of 0.05 wt% (0.05), 0.1 wt% (0.1), 0.2 wt% (0.2), 0.4 wt% 
(0.4), or 0.5 wt% (0.5) PGA was added to the solution before 
adding AgNO3. The preparation was completed in a single 
reaction vessel to facilitate fabrication.
Ultraviolet spectroscopy
Ultraviolet measurements were performed using a GBC 
Cintra ultraviolet-visible spectrophotometer at a frequency 
interval of 200–600 nm. Ultraviolet-visible spectroscopy 
was used to estimate the extent of formation of silver nano-
particles during the reaction, the formation of PGA-capped 
silver nanoparticles, the stability of the silver nanoparticles 
over a given time period, and the extent of formation of 
silver nanoparticles using different amounts of capping 
agent, ie, the influence of capping agent concentration on 
the final products.
Fourier-transform infrared spectroscopy
Analysis of the quality of the samples was performed using 
Fourier transform infrared (FTIR) spectroscopy. FTIR spectra 
for the samples were recorded in the range of 400–4000 cm-1 
using a Specord 75 spectrometer (Carl Zeiss, Jena, Germany) 
at 4 cm-1 resolution. FTIR measurements of the samples 
were carried out to identify possible interactions between 
silver and PGA which might be responsible for stabilization, 
ie, protection of the silver nanoparticles from agglomeration 
and rendering them biocompatible.
Field emission scanning electron 
microscopy
Observation of the microstructure of the bare and capped 
silver nanoparticles using different amounts of PGA as 
the capping agent was done using field-emission scanning 
electron microscopy (FESEM). FESEM measurements were 
performed on a Supra 35 VP field-emission scanning electron 
microscope (Carl Zeiss). The samples were prepared by 
redispersion in ethanol using an ultrasonic bath and filtering 
the dispersions using polycarbonate membranes. Carbon 
coating was used to prevent charging.
Transmission electron microscopy
Transmission electron microscopy (TEM) with a JEM-2100 
(JEOL, Peabody, MA) was employed for further morpho-
logical characterization of the bare and PGA-capped silver 
nanoparticles by exploring the individual nanostructures. 
Samples for the TEM analysis were prepared by dispersing 
the powders in distilled water using an ultrasonic bath. The 
suspensions were subsequently dropped on a lacey carbon 
film supported by a 300-mesh copper grid.
Zeta potential measurement
The zeta potential was measured using a Zetasizer (Nano ZS, 
Model ZEN3600, Malvern Instruments, Worcestershire, UK), 
with a particle size range for zeta potential determination of 
5–10 µm, using the principle of electrophoretic mobility 
under an electric field. The zeta potential is a function of the 
dispersion/suspension pH which determines particle stability 
in dispersion.
cell culture
HepG2 cells were obtained from the European Collection 
of Cell Cultures. The cells were grown in Eagle’s minimal 
essential medium containing 10% fetal bovine serum, 1% 
nonessential amino acid solution, 2 mM L-glutamine, and 
100 U/mL penicillin plus 100 µg/mL streptomycin at 37°C 
in a humidified atmosphere and 5% CO2.
cytotoxicity of bare and PgA-capped 
silver nanoparticles
The cytotoxicity of the bare and PGA-capped silver nano-
particles was determined using the MTT assay according 
to Mosmann,29 with minor modifications.30 This assay 
measures the conversion of MTT to insoluble formazan International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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by dehydrogenase enzymes from the intact mitochondria 
of living cells.
HepG2 cells were seeded into 96-well microplates 
(Nunc, Naperville, IL) at a density of 40,000 cells/mL and 
incubated for 20 hours at 37°C for attachment. The medium 
was then replaced by fresh complete medium containing 
0%, 0.01%, 0.1%, 1%, and 10% v/v of bare and PGA-
capped silver nanoparticles, and incubated for 24 hours. In 
each experiment, a negative control (nontreated cells) and 
vehicle control (10% emulsion) was included. MTT (final 
concentration 0.5 mg/mL) was then added, and incubated for 
a further 3 hours. In the next step, the medium and MTT was 
removed, and the   formazan crystals formed were dissolved 
in dimethylsulfoxide. The optical density was measured at 
570 nm (reference filter 690 nm) using a microplate-reading 
spectrofluorometer (Tecan Genios, MTX Lab Systems Inc, 
Vienna, VA).   Survival (viability) was determined by com-
paring the optical density of the wells containing the treated 
cells with those of the nontreated cells. Five replicates per 
concentration point and three independent experiments were 
performed.
The results are expressed as the mean values of three 
independent experiments. One-way analysis of variance 
(Kruskal-Wallis) was used for evaluation of the statistical 
significance of any differences between the exposed and 
control cells and between cells exposed to bare and PGA-
capped silver nanoparticles. P , 0.05 was considered to be 
statistically significant.
Intracellular reactive oxygen species 
formation
Formation of intracellular reactive oxygen species was 
measured spectrophotometrically using a fluorescent probe, 
ie, DCFH-DA, as described by Osseni et al,31 with minor 
modifications.32 DCFH-DA readily diffuses through the 
cell membrane and is hydrolyzed by intracellular esterases 
to nonfluorescent 2′,7′-dichlorofluorescein. It is then 
  rapidly   oxidized to highly fluorescent 2′,7′- DCFH-DA in 
the presence of reactive oxygen species. The fluorescence 
  intensity is proportional to the amount of intracellular   reactive 
oxygen species formed.
HepG2 cells were seeded at a density of 75,000 cells/mL 
in 96-well, black, tissue culture-treated microtiter plates 
in five replicates. After 20 hours of incubation at 37°C in 
5% CO2, the cells were incubated with 20 µM DCFH-DA. 
After 30 minutes, DCFH-DA was removed and the cells 
were treated with 0%, 0.01%, 0.1%, 1%, and 10% v/v of 
the bare and PGA-capped silver nanoparticles in phosphate-
buffered saline. Negative (nontreated cells), vehicle (10% 
emulsion), and positive control (0.5 mM t-BOOH) groups 
were included in each experiment. For the kinetic analyses, 
the dishes were maintained at 37°C and the fluorescence 
intensity was determined every 30 minutes during a 5-hour 
incubation using the microplate-reading spectrofluorometer 
at an excitation wavelength of 485 nm and an emission 
wavelength of 530 nm.
Statistically significant differences between the treated 
groups and controls, and between cells treated with bare 
and PGA-capped silver nanoparticles were determined 
by   one-way analysis of variance (Kruskal-Wallis) with 
  Dunnett’s test and Bonferroni’s post-test, respectively. 
P , 0.05 was considered to be statistically significant.
Results and discussion
Ultraviolet-visible spectroscopy
The ultraviolet-visible absorption results confirmed formation 
of bare and PGA-capped silver nanoparticles prepared by 
new, simple, green, one-pot four-component synthesis 
(Figure 1). The successful synthesis of bare and PGA-capped 
silver nanoparticles was first indicated by the distinctive color 
that appeared in the colloidal solution. Initially, reduction 
of silver ions leads to formation of silver atoms, followed 
by agglomeration into clusters.6 These clusters eventually 
lead to formation of colloidal silver particles.6 When the 
colloidal particles are much smaller than the wavelength of 
visible light, the solutions develop a yellow color with an 
intense band around 400 nm.33 This band is attributable to 
collective excitation of the electron gas in the particles, with 
a periodic change in electron density at the surface (surface 
plasmon absorption).33,34
Silver nanoparticles are especially valued for their 
optical properties, being useful for surface-enhanced 
Raman scattering, imaging, sensing, and wave guiding 
applications, where the optical absorption arising from the 
surface plasmons of noble metal materials is important. The 
position and shape of the surface plasmon absorption band 
is strongly dependent on the size and shape of the particle, 
the dielectric constant of the medium, and surface-adsorbed 
species.33–35
The ultraviolet-visible spectra for bare silver nanoparticles 
shows only one dominant, broad absorption band around 
421 nm, which represents the typical signature of the 
dipolar plasmon resonance of silver nanoparticles.33–35 
The ultraviolet-visible absorption spectra of the silver 
nanoparticles capped with different concentrations of PGA 
were also investigated in our study. Ultraviolet-visible 
absorption spectra for the PGA (0.05)-capped silver nano-
particles and PGA (0.1)-capped silver nanoparticles showed International Journal of Nanomedicine 2011:6
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Figure 1 (A) UV-visible spectra of bare silver nanoparticles and capped with different amounts of PgA as capping agent, (B) Absorbance maximum displacement depending 
on the concentration of capping agent; (C) Increase of the absorbance maximum depending on the concentration of capping agent and (D) Stability of bare and PgA capped 
silver nanoparticles three months after synthesis.
Abbreviations: PgA, poly-α, γ, L-glutamic acid; AgNpPgA, PgA-capped silver nanoparticles.
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narrow surface plasmon absorption bands at 411 nm and at 
404 nm wavelengths, respectively. The maximum absorption 
displacement for the PGA (0.05)-capped silver nanoparticles 
as well as for the PGA (0.1)-capped silver nanoparticles at 
the smaller wavelengths (blue shift) indicates a change in 
particle size to smaller dimensions (Figure 1B). It is well 
known from the literature that a polaritonic blue shift occurs 
with decreasing cluster size and a red shift occurs with 
increasing cluster size, due to electromagnetic retardation.33 
Shifting of the absorption band to shorter wavelengths also 
indicates that the particles became more spherical with the 
addition of PGA. Although it was expected that this trend 
would continue with further increases in PGA concentration, 
Figure 1 shows that this did not happen for the PGA (0.2), 
(0.4) or (0.5)-capped silver nanoparticles. With increases 
in PGA concentration beyond 0.1%, the absorption spectra 
become broader, with a decrease in absorbance, and also 
showed red-shifted peaks at 412 nm, 413 nm, and 416 nm 
for PGA (0.02), (0.4) and (0.5)-capped silver nanoparticles, 
respectively (Figure 1A, B, and C). It was observed that 
the absorption spectrum for PGA (0.4)-capped silver 
nanoparticles became very broad, with a decrease in absor-
bance at 413 nm and a shoulder appearing around 485 nm. 
  Resonances of higher multipolar order appeared in addi-
tion to the usual dipolar resonance when the cluster size 
increased, so the optical field became nonuniform across 
the cluster. In clusters of nonspherical shape, the single 
dipolar resonance of the spherical case splits into two or 
more nondegenerate plasmon modes that differ in their 
oscillation directions.33,34 All these observations indicate 
that the optimum concentration of PGA for formation of 
PGA-capped silver nanoparticles is 0.1%.International Journal of Nanomedicine 2011:6
Table 1 Assignment, vibrational modes, and positions (wave number in cm-1) of FTIr bands in the spectra of PgA, AgNpPgA (0.1), 
and AgNpPgA (0.4)
Assignment Vibrational modes Band position (cm-1) Appearance
PGA AgNpPGA (0.1) AgNpPGA (0.4)
O-h Stretching 3380 3410 3400 Broad and strong
Amide I Associated amides 1650 1600 1630 Medium to strong
c=O Symmetric 1400 1400 1390 Medium to strong
N-h (δ) In-plane bending or scissoring 1300 1300 1300 Weak to medium
c-N Stretching 1050 1080 1150 Broad and strong
N-h (ω) Out-of-plane bending or wagging 760 730 750 Weak
Abbreviations: FTIr, Fourier transform infrared spectroscopy; PgA, poly-α, γ, L-glutamic acid; AgNpPgA, PgA-capped silver nanoparticles.
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The stability of nanoparticle dispersions is a key   factor in 
their successful application. In order to prevent agglomeration 
of the nanoparticles, different concentrations of capping 
agent were added to the reaction media. The absorption 
spectra of solutions containing PGA (0.1)-capped silver 
nanoparticles, recorded immediately after preparation and 
after three months of storage, confirmed very good stability 
of the samples as opposed to samples containing bare silver 
nanoparticles or silver nanoparticles capped with more than 
0.1% PGA (Figure 1D).
Fourier-transform infrared spectroscopy
The origins of the bonding between the silver nanoparticle 
surface and the capping molecule were investigated by 
FTIR spectroscopy. In the FTIR analysis, PGA was used 
as a   comparison sample. The infrared spectra of the PGA 
and PGA-capped silver nanoparticles in the KBr pellet 
showed strong characteristic C–N stretching at about 1000–
1150 cm-1, carbonyl absorption at about 1390–1420 cm-1, 
and strong hydroxyl absorption at 3200–3550 cm-1.36 
The absorption peaks at 3380–3410 cm-1 were indicative 
of N–H stretching.37,38 The absorption peaks at around 
1600–1690 cm-1 and 1395–1400 cm-1 were characteristic of 
amide groups and C=O groups. Glutamic acid, the building 
monomer of polyglutamic acid, possesses three chemically 
active functional groups, ie, α-NH2, α-COOH, and γ-COOH. 
The chemical reactivity of these three functional groups 
follows the order α-NH2 . α-COOH, . γ-COOH.41 The 
FTIR spectra for PGA and the PGA-capped silver nano-
particles confirmed the presence of carboxyl, hydroxyl, 
carbonyl, and amide groups.
Comparing the FTIR spectra obtained for PGA (0.1)-
capped silver nanoparticles and PGA (0.4)-capped silver 
nanoparticles with the characteristic FTIR spectra of PGA, it 
is reasonable to believe that the silver nanoparticles obtained 
were capped with PGA. Details of the spectra interpretation 
and band assignments are shown in Table 1.
Field emission scanning electron 
microscopy
The morphological characteristics of the bare silver nanopar-
ticles and those capped with different amounts of PGA were 
observed by FESEM. The FESEM images show the crucial 
influence of the amount of capping agent on the morphol-
ogy of silver nanoparticles. Figure 2A shows the FESEM 
micrographs recorded for the bare silver nanoparticles, from 
which one can see that the particles are much agglomerated. 
The bare silver nanoparticles have been joined together and 
assembled, forming clusters, fibers, and a rope-like structure. 
The main reason for this phenomenon is lack of use of a 
stabilizer in the experiment.
Figure 2B shows the FESEM images for the microstruc-
ture of silver nanoparticles capped with 0.4% of PGA. These 
particles are much agglomerated and have formed a film, on 
which cracks and roughness can be seen, and sporadically 
distributed spherical particles of smaller and larger sizes 
are still present. From these results, it is obvious that the 
concentration of capping agent must be optimized in order to 
obtain the smallest particle dimensions using this method, as 
well as to keep agglomeration to a minimum. A 0.4% PGA 
concentration is clearly too high for this method.
The micrograph for silver nanoparticles capped with 0.1% 
of PGA shows that the particles have a nearly spherical shape, 
are smooth-surfaced, and have a low level of agglomeration 
and a high level of uniformity (Figure 3). The size distribu-
tion of all nanoparticles was unimodal, with particle sizes 
of about 5–45 nm.
Transmission electron microscopy
The silver nanoparticles obtained at various capping agent/
silver ratios were also examined by TEM. Silver nanopar-
ticles obtained in the experiment without PGA showed 
irregular morphology with a broad size distribution. From 
Figure 4A it can be seen that lack of a stabilizer in the system 
leads to formation of agglomerates. Further analyses of the International Journal of Nanomedicine 2011:6
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Figure 3 (A) Scheme of the green synthesis of the bare and capped silver nanoparticles. (B) FeSeM images of capped silver nanoparticles with 0.1% PgA (inset shows 
arbitrarily magnified particle).
Abbreviations: AgNp, silver nanoparticles; FeSeM, Field emission Scanning electron Microscope; PgA, PgA, poly-α, γ, L-glutamic acid.
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Figure 2 Images of AgNp particles obtained in the experiment without PgA (A) 
and with 0.4% PgA (B).
Abbreviations: FeSeM, field emission scanning electron microscope; PgA, poly-α, 
γ, L-glutamic acid
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0.1% PGA-capped silver nanoparticles using TEM showed 
nearly spherical nanoparticles with diameters in the range 
of 5–45 nm. From Figure 4B, it is clear that the particles 
had a low level of agglomeration and a high level of uni-
formity. TEM images of silver nanoparticles capped with 
0.4% PGA confirm the majority of the previously mentioned 
considerations. These nanoparticles have irregular shapes and 
are very much agglomerated (Figure 4C). Both the FESEM 
and TEM images demonstrate that the use of different 
amounts of PGA leads to nanoparticles with significantly 
different morphologies.
The proposed mechanism for formation of colloidal 
PGA-capped silver nanoparticles is shown in Figure 5. The 
observations reported here suggest that formation of PGA-
capped silver nanoparticles from AgNO3 comprises several 
steps. In the first step, silver ions are reduced, leading to 
formation of silver clusters. In the second step, absorption 
of PGA onto the surface of silver clusters, further reduction 
of adjacent silver ions, and their accumulation on silver 
clusters occurs, followed by growth of the silver particles 
and colloidal stabilization by PGA. Flexible linkage of PGA 
and the large number of molecules in the reaction solution 
leads to isotropic growth and the formation of stable spherical 
silver nanoparticles. With further increases in PGA concen-
tration, large-sized silver nanoparticles and agglomerates 
are formed. As a consequence, in a colloidal suspension of 
given concentration, excessive concentration of polymers 
leads to an increasing number of bridges (polymers intercon-
necting different aggregates), and finally to the formation 
of a three-dimensional polymer network (see Figures 2B, 
4C, and 5).38International Journal of Nanomedicine 2011:6
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Figure 4 TeM images of bare silver nanoparticles (A), capped with 0.1% PgA (B) and with 0.4% PgA (C).
Abbreviations: TeM, transmission electron microscope; PgA, poly-α, γ, L-glutamic acid.
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C
Figure 5 Scheme representing proposed formation of colloidal silver nanoparticles 
without PgA (A) with optimal (B) and excessive (C) concentration of PgA.
Abbreviation: PgA, poly-α, γ, L-glutamic acid.
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Zeta potential
The results of zeta potential determination for the bare and 
PGA-capped silver nanoparticles are shown in Table 2. The 
zeta potential was reported as the average of five readings 
taken per sample, including the standard deviation. The zeta 
potential is directly proportional to the stability of a colloid. If 
all the particles in a colloid have a large negative or positive 
zeta potential, they will tend to repel each other and there will 
be a low likelihood of the particles coming together. PGA 
was used as a stabilizer, creating negatively charged silver 
particles with a specific zeta potential.
The particle size was lower for silver nanoparticles stabi-
lized and capped with 0.05% and 0.1% PGA compared with 
the bare nanoparticles. Although the PGA layer   contributes to 
the size of the particles, this serves as evidence of reduction in 
particle size, aiding precipitation of the silver nanoparticles, 
presumably by adsorbing onto the growing particle facets. 
However, this is not the case for particles capped with 0.4% 
PGA. The polydispersity index, which is a dimensionless 
number indicating the width of a size distribution and having 
a value between 0 and 1, was also determined. Narrow disper-
sions have polydispersity index values ,0.2, broader disper-
sions have values of 0.2–0.5, and very dispersed particles 
have values .0.5.39,40 According to Table 2, dispersions of 
PGA (0.05)-capped and (0.1)-capped silver nanoparticles had 
polydispersity index values slightly higher than 0.2, which 
is in good agreement with the results obtained by FESEM 
and TEM. It is also shown in Table 2 that PGA (0.4)-capped 
silver nanoparticles are widely dispersed particles.
Zeta potentials for all the samples, except for PGA 
(0.4)-capped silver nanoparticles, are higher than -30 mV , 
indicating good stability of this colloidal system.41 Electro-
phoretic mobility is inversely proportional to the viscosity 
of the medium, and viscosity is directly proportional to 
PGA concentration, so electrophoretic mobility decreases 
with increasing concentrations of PGA.42 The zeta potential 
is directly proportional to electrophoretic mobility42 
(according to the Henry equation: UE = 2εzf(ka)/3η, where 
UE = electrophoretic mobility, ε = the dielectric constant, 
z = the zeta potential, η = viscosity and f(ka) = Henry’s 
function), and both the zeta potential and colloidal stability International Journal of Nanomedicine 2011:6
Table 2 Zeta potential results for bare and PgA-capped silver nanoparticles
Sample Particle size (nm) pH PDI Zeta potential (mV)
AgNp   69.2 ± 5.0 4.30–4.37 0.235 -38.5 ± 11.5
AgNpPgA (0.05)   47.5 ± 5.0 0.201 -49.1 ± 19.0
AgNpPgA (0.1)   44.9 ± 5.0 0.206 -43.7 ± 12.0
AgNpPgA (0.4) 179.0 ± 5.0 0.707 -10.8 ± 3.8
Note: Values are mean ± standard deviation (n = 5). 
Abbreviations: PDI, polydispersity index; PgA, poly-α, γ, L-glutamic acid; AgNpPgA, PgA-capped silver nanoparticles.
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Figure 6 Viability of hepg2 cells treated with AgNp or AgNpPgA (0.1) for 24 h. 
The data are presented as mean values of three independent experiments (each with 
five replicates) ±SD. 
Note: *P , 0.05 statistically significant difference (ANOVA, Kruskal-Wallis).
Abbreviations: AgNp, silver nanoparticles; AgNpPgA, PgA-capped silver nanopar-
ticles; SD, standard deviation; PgA, poly-α, γ, L-glutamic acid.
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decreased with increasing PGA concentrations, which 
is in good agreement with the ultraviolet-visible results 
(Figure 1D).
In vitro cytotoxicity of bare  
and PgA-capped silver nanoparticles
The cytotoxicity of the bare and PGA (0.1)-capped silver 
nanoparticles was determined by MTT assay after exposure 
of HepG2 cells to 0%, 0.01%, 0.1%, 1%, and 10% v/v of sil-
ver nanoparticles and PGA (0.1)-capped silver nanoparticles 
for 24 hours. Cell viability data for the vehicle control are 
not shown in Figure 6 because they were almost identical to 
the negative control. At concentrations up to 1% (v/v), both 
types of particles exerted a similar effect on the viability 
of HepG2 cells. At these concentrations, the viability was 
not reduced by more than 20% compared with nontreated 
controls. At 10% (v/v), the silver nanoparticles reduced 
cell viability by 35% compared with the control, while the 
viability of cells exposed to 10% (v/v) PGA (0.1)-capped 
silver nanoparticles was reduced by 17% (Figure 6).
Induction of intracellular reactive  
oxygen species
To establish the influence of bare and PGA (0.1)-capped 
silver nanoparticles on intracellular reactive oxygen species 
formation, we measured the kinetics of their formation in 
HepG2 cells by DCFH-DA assay. Reactive oxygen species 
induction data for the vehicle control are not shown in 
Figure 7, because they were almost identical to those of the 
negative control.
Both samples induced a significant increase in forma-
tion of intracellular reactive oxygen species, but only at the 
highest tested concentration (10% v/v), whereas the bare 
silver nanoparticles had a stronger influence on formation of 
reactive oxygen species compared with PGA (0.1)-capped 
silver nanoparticles. Reactive oxygen species formation 
increased by 2.2-fold after five hours of exposure to the bare 
silver nanoparticles and was 1.8-fold higher than in control 
cells after exposure to PGA (0.1)-capped silver nanoparticles 
(Figure 7).
Conclusion
In conclusion, bare and PGA-capped silver nanoparticles 
were successfully synthesized using a new, simple, green, 
one-pot, four-component method. The cytotoxic potential 
and influence of these nanoparticles on formation of intra-
cellular reactive oxygen species was investigated in vitro. 
A naturally occurring anionic polymer was used as the organic 
layer to protect the silver nanoparticles from agglomeration 
and render them biocompatible, and glucose was used as a 
reducing agent. One of the advantages of this method is that 
ammonia (a caustic and hazardous chemical) is not used 
during synthesis. This method represents an attractive, rapid, 
and low-cost process with the potential for industrial scale-up. 
However, appropriate optimization is necessary to be able to 
develop silver nanoparticles with a narrow size distribution. 
Observations using ultraviolet-visible spectroscopy, FESEM, 
TEM, and zeta potential measurement indicate that these 
silver nanoparticles agglomerate if PGA is not used during 
synthesis and if there is an excessive concentration of PGA. 
The capped silver nanoparticles obtained in this experiment 
using the optimum concentration of PGA 0.1% were uniform 
and nonagglomerated, had a narrow particle size distribution, 
and were highly stable for several months. This PGA concen-
tration should be used for manufacture of PGA-capped silver 
nanoparticles when scaled up to large batches. The MTT assay International Journal of Nanomedicine 2011:6
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Figure 7 AgNp and AgNpPgA (0.1)-induced intracellular rOS formation in hepg2 cells. Kinetic of rOS formation during 5 hour exposure to AgNp or AgNpPgA (0.1) 
(A and B); each point represents the mean of five replicates (±SD) of representative experiment. Increase of DcFh fluorescence intensity in cells exposed to AgNp or 
AgNpPgA (0.1) after 5 hour exposure (C); each bar represent means (±SD) of three independent experiments. Pc (0.5 mM t-BOOh). 
Note: *P , 0.05; statistically significant difference (ANOVA, Kruskal-Wallis).
Abbreviations: DcF, 2-7-dichlorofluorescin; PgA, poly-α, γ, L-glutamic acid; AgNp, silver nanoparticles; AgNpPgA, PgA-capped silver nanoparticles; rOS, reactive oxygen 
species; DcFh, 2-7-dichlorofluorescin; SD, standard deviation; Pc, positive control.
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results indicated that PGA (0.1)-capped silver nanoparticles 
have good biocompatibility, and do not increase the produc-
tion of reactive oxygen species by HepG2 cells in vitro.
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